CASI Pharmaceuticals, Inc. (CASI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 43.41M |
| Enterprise Value | 52.09M |
| P/E Ratio | -0.04 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.1 |
| Price/Book Ratio | -0.04 |
| Enterprise/Revenue | 1.93 |
| Enterprise/EBITDA | -1 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | -2.19 |
| Operating Margin | -1.91 |
AD
Management Effectiveness
| Return On Assets | -2.09 |
| Return On Equity | 0.96 |
Income Statement
| Revenue | 28.54M |
| Revenue/Share | 0.98 |
| Gross Profit | 11.15M |
| EBITDA | -34.87M |
| Net Income | -39.26M |
| Diluted EPS | -2.56 |
Balance Sheet
| Total Cash | 4.68M |
| Total Cash/Share | 0.18 |
| Total Debt | 18.86M |
| Total Debt/Equity | -0.7 |
| Current Ratio | 0.15 |
| Book Value Per Share | -2.83 |
Price History
| 52-Week Change | -92.2 |
| 52-Week High | 3.09 |
| 52-Week Low | 0.14 |
| Moving Average 50 Days | 0.86 |
| Moving Average 200 Days | 1.44 |
Statistics
| Average Volume | 225,203 |
| Shares Outstanding | 20.56M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 02, 2022 |
AD
